Dolby Laboratories Inc’s recent filing unveils that its President and CEO YEAMAN KEVIN J unloaded Company’s shares for reported $1.79 million on Sep 16 ’25. In the deal valued at $71.66 per share,25,000 shares were sold. As a result of this transaction, YEAMAN KEVIN J now holds 114,725 shares worth roughly $8.21 million.
Then, YEAMAN FAMILY TRUST U/A DTD 05 bought 25,000 shares, generating $1,791,488 in total proceeds.
Before that, Revankar Shriram sold 7,000 shares. Dolby Laboratories Inc shares valued at $524,440 were divested by the SVP, Advanced Technology Group at a price of $74.92 per share. As a result of the transaction, Revankar Shriram now holds 70,435 shares, worth roughly $5.04 million.
Robert W. Baird initiated its Dolby Laboratories Inc [DLB] rating to a Neutral in a research note published on September 05, 2025; the price target was $74. Barrington Research also remained covering DLB and has increased its forecast on June 03, 2024 with a “an Outperform” recommendation from previously “Mkt perform” rating. Barrington Research revised its rating on November 18, 2022. It rated DLB as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of DLB
On Friday, Dolby Laboratories Inc [NYSE:DLB] saw its stock fall -0.72% to $71.58. Over the last five days, the stock has gained 0.20%. Dolby Laboratories Inc shares have fallen nearly -0.42% since the year began. Nevertheless, the stocks have fallen -8.35% over the past one year.
How much short interest is there in Dolby Laboratories Inc?
A steep rise in short interest was recorded in Dolby Laboratories Inc stocks on 2025-08-29, growing by 0.35 million shares to a total of 1.82 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 1.48 million shares. There was a rise of 18.95%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 24, 2022 when Rosenblatt began covering the stock and recommended ‘”a Buy”‘ rating along with a $90 price target.
